Rift Valley fever MP-12 vaccine Phase 2 clinical trial: Safety, immunogenicity, and genetic characterization of virus isolates

Phillip R. Pittman, Sarah L. Norris, Elizabeth S. Brown, Manmohan V. Ranadive, Barbara A. Schibly, George E. Bettinger, Nandadeva Lokugamage, Lawrence Korman, John C. Morrill, Clarence J. Peters

Research output: Contribution to journalArticle

17 Scopus citations

Fingerprint Dive into the research topics of 'Rift Valley fever MP-12 vaccine Phase 2 clinical trial: Safety, immunogenicity, and genetic characterization of virus isolates'. Together they form a unique fingerprint.

Agriculture & Biology

Medicine & Life Sciences